List of high-quality authors
Zhenhai shares: some directors, supervisors and senior executives have increased their holdings by 00573% of the company's shares.
Xuantai Pharmaceutical: The controlling shareholder proposed to repurchase shares for 35 million yuan to 70 million yuan.
Dibei Electric: The actual controller intends to increase his holdings of the company's shares with 20 million yuan.
Yingfeng shares: The actual controller plans to spend 8 million to 15 million yuan to increase the company's shares.
Lao Bai Dry Wine: The controlling shareholder promises not to ** the company's shares within 12 months.
Huiyu Pharmaceutical: The subsidiary's **Lanin for injection obtained marketing authorization in the United Kingdom.
Guanggang Gas: It is planned to build an air separation gas intelligent equipment manufacturing base project in Jiande Economic Development Zone.
Yongxin Zhicheng: It is planned to repurchase shares for 30 million yuan to 60 million yuan.
Duolun Technology: The chairman proposed to repurchase shares for 30 million yuan to 60 million yuan.
The chairman of Dizhe Pharmaceutical has increased his holdings by 16100,000 shares.
Xili Technology: It is planned to repurchase shares for 30 million yuan to 50 million yuan.
Xinjiang Tianye: A wholly-owned subsidiary of the controlling shareholder intends to rebuke 07.5 billion to 1500 million yuan to increase the company's shares.
BTG Hotel: The controlling shareholder promised not to ** the company's shares within 12 months.
Mabwell: Obtained FDA approval for the investigational trial application of 7MW3711 for injection.
Rendu Bio: It is planned to repurchase shares for 25 million yuan to 50 million yuan.
The content of the article belongs to the collation and statistics of public information, and does not constitute a recommendation or any basis for buying and selling.